Anuh Pharma Limited (NSE:ANUHPHR)
79.90
-0.14 (-0.17%)
Jul 22, 2026, 3:29 PM IST
Anuh Pharma Market Cap
Anuh Pharma has a market cap or net worth of 8.1 billion as of July 22, 2026. Its market cap has decreased by -21.83% in one year.
Market Cap
8.10B
Enterprise Value
7.57B
Revenue
7.72B
Ranking
n/a
PE Ratio
19.73
Stock Price
79.90
ChartMarket Cap Chart
Since January 2, 2008, Anuh Pharma's market cap has increased from 219.45M to 8.10B, an increase of 3,589.78%. That is a compound annual growth rate of 21.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 8.10B | 0.39% |
| Dec 31, 2025 | 8.07B | -28.75% |
| Dec 31, 2024 | 11.32B | 54.09% |
| Dec 29, 2023 | 7.35B | 64.17% |
| Dec 30, 2022 | 4.48B | -15.60% |
| Dec 31, 2021 | 5.30B | -22.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solara Active Pharma Sciences | 27.47B |
| Beta Drugs | 24.62B |
| Indoco Remedies | 22.57B |
| Ind-Swift Laboratories | 20.29B |
| Sakar Healthcare | 20.00B |
| Windlas Biotech | 17.99B |
| Jagsonpal Pharmaceuticals | 14.97B |
| Sigachi Industries | 9.75B |